Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients with Multiple Sclerosis

• Thomas F. Benkert ,

  Contributed equally to this work with: Thomas F. Benkert, Lena Dietz

  Affiliations Department of Molecular Pathology, University of Würzburg, Würzburg, Germany, Institute of Pathology, University of Würzburg, Würzburg, Germany

  ⨯
• Lena Dietz ,

  Contributed equally to this work with: Thomas F. Benkert, Lena Dietz

  Affiliations Department of Molecular Pathology, University of Würzburg, Würzburg, Germany, Institute of Pathology, University of Würzburg, Würzburg, Germany

  ⨯
• Elena M. Hartmann,

  Affiliation Institute of Pathology, University of Würzburg, Würzburg, Germany

  ⨯
• Ellen Leich,

  Affiliation Institute of Pathology, University of Würzburg, Würzburg, Germany

  ⨯
• Andreas Rosenwald,

  Affiliation Institute of Pathology, University of Würzburg, Würzburg, Germany

  ⨯
• Edgar Serfling,

  Affiliations Department of Molecular Pathology, University of Würzburg, Würzburg, Germany, Institute of Pathology, University of Würzburg, Würzburg, Germany

  ⨯
• Mathias Buttmann ,

  ¶These authors also contributed equally to this work.

  Affiliation Department of Neurology, University of Würzburg, Würzburg, Germany

  ⨯
• Friederike Berberich-Siebelt

  * E-mail: path230@mail.uni-wuerzburg.de

  ¶These authors also contributed equally to this work.

  Affiliations Department of Molecular Pathology, University of Würzburg, Würzburg, Germany, Institute of Pathology, University of Würzburg, Würzburg, Germany

  ⨯